Document is current
Any future updates will be listed below
-
Authors
Emanuels, Anne
Casto, Amanda M.
Heimonen, Jessica
O’Hanlon, Jessica
Chow, Eric J.
Ogokeh, Constance
Rolfes, Melissa A.
Han, Peter D.
Hughes, James P.
Uyeki, Timothy M.
Frazar, Christian
Chung, Erin
Starita, Lea M.
Englund, Janet A.
Chu, Helen Y.
,
Boeckh, Michael
Famulare, Michael
Lutz, Barry R.
Nickerson, Deborah A.
Rieder, Mark J.
Thompson, Matthew
Shendure, Jay
Bedford, Trevor
Adler, Amanda
Brandstetter, Elisabeth
Burstein, Roy
Cho, Shari
Geyer, Rachel E.
Hadfield, James
Jackson, Michael L.
Kiavand, Anahita
Kim, Ashley E.
Kimball, Louise E.
Kotnik, Jack Henry
Lacombe, Kirsten
Logue, Jennifer K.
Lyon, Victoria
McCulloch, Denise J.
Richardson, Matthew
Rogers, Julia H.
Sibley, Thomas R.
Zigman Suchsland, Monica L.
Truong, Melissa
Wolf, Caitlin R.
Zhong, Weizhi
- License Information
-
More Information
Article History
Received: 7 December 2022
Accepted: 21 February 2024
First Online: 13 March 2024
Declarations
:
: The study was approved by the University of Washington Institutional Review Board and the Centers for Disease Control and Prevention relied on that review and approval. Informed consent was obtained from all the participants and from the legal guardians of the participants who were below 16 years of age. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: Dr. Chu reported consulting with Ellume, Pfizer, The Bill and Melinda Gates Foundation, Glaxo Smith Kline, and Merck. She has received research funding from Gates Ventures, Sanofi Pasteur, and support and reagents from Ellume and Cepheid outside of the submitted work. Dr. Englund reported consulting with Sanofi Pasteur, AstraZeneca, and Meissa Vaccines, and has received research funding from AstraZeneca, GlaxoSmithKline, Merck, and Pfizer outside the submitted work. All remaining authors have no competing interests to declare.
